Skip to Content

93 7477 (Mycophenolate mofetil 500 mg)

Pill imprint 93 7477 has been identified as Mycophenolate mofetil 500 mg.

Mycophenolate mofetil is used in the treatment of nephrotic syndrome; systemic lupus erythematosus; dermatomyositis; organ transplant, rejection prophylaxis; rheumatoid arthritis (and more), and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Mycophenolate mofetil 500 mg is not a controlled substance under the Controlled Substance Act (CSA).

Mycophenolate mofetil 500 mg 93 7477
Mycophenolate mofetil 500 mg 93 7477
Mycophenolate mofetil 500 mg 93 7477
Mycophenolate mofetil
93 7477
500 mg
18.00 mm
Elliptical / Oval
Prescription only
Drug Class:
Selective immunosuppressants
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Teva Pharmaceuticals USA
National Drug Code (NDC):
Inactive Ingredients:
croscarmellose sodium
FD&C Blue No. 2
aluminum oxide
FD&C Red No. 40
hypromellose 2910 (6 mPa.s)
magnesium stearate
microcrystalline cellulose
polyethylene glycol 400
povidone k30
magnesium silicate
titanium dioxide

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.